This message was sent to ##Email##
|
|
|
|
|
|
Advertisement
|
|
|
NPR
For years, doctors have focused on detecting breast cancer at the earliest possible moment after a tumor develops so treatment can start right away. But more and more studies are showing many small, early tumors don't present a danger.
So, when is it safe to remove a tumor but skip additional treatments like tamoxifen, chemotherapy and radiation?
READ MORE
|
Promoted by
|
|
|
|
 |
Medical Xpress
Many breast cancer patients depend on family and friends to help them make treatment decisions, get to doctor appointments and seek out other resources. A new study finds half of women rely on three or more people to help them through it.
"People just diagnosed with cancer are often scared and overwhelmed. Having another person to help them process information is important," said study lead author Lauren Wallner, an assistant professor of general medicine and epidemiology at the University of Michigan.
READ MORE
STAT News
The FDA has weighed in on Novartis’ pioneering personalized cancer therapy, which looks almost certain to win approval. But the agency is wading into uncharted territory, bringing along a bevy a questions on manufacturing and long-term safety to a hotly anticipated public forum.
In briefing documents released before a Wednesday hearing on Novartis’ treatment, FDA staff made clear that it has little doubt the therapy is effective in treating advanced cases of leukemia in children and young adults.
READ MORE
Oncology Nurse Advisor
The U.S. Food and Drug Administration granted clearance for expanded use of DigniCap Cooling System, a cooling cap to reduce hair loss (alopecia) to include cancer patients with solid tumors. The FDA had previously cleared the device for use just in patients with breast cancer in 2015.
Alopecia is a common side effect of chemotherapy and is observed frequently in the treatment of most solid tumor cancers.
READ MORE
|
Promoted by
|
|
|
|
 |
MedPage Today
Patients with early-stage breast cancer often undergo definitive surgery without genetic testing, or before BRCA1/2 testing has been performed, and the results frequently aren't explained to them, a survey of surgeons and patients found.
Approximately one-third of surgeons said they rarely referred patients for genetic counseling, and only 73 percent of high-volume surgeons and 35 percent of lower-volume surgeons said they were confident in discussing genetic test results with their patients, reported Allison Kurian, MD, of the Stanford University School of Medicine in California, and colleagues.
READ MORE
Medscape
The U.S. Food and Drug Administration has approved L-glutamine oral powder to reduce severe complications of sickle cell disease in patients aged 5 years and older with the disorder. This is the first approved treatment for the rare disorder in almost 20 years.
READ MORE
 |
|
Our ihcDirect™ method yields a revolutionary technology that opens a spectrum of new clinical applications including intraoperative surgery. Using the Novodiax PolyHRP technology, Intraoperative IHC tests can now be completed in just 10 minutes using fresh frozen tissues.
For more details, see our ihcDirect™ product list.
|
|
ACS
The 2017 Cancer Programs Conference: Creating a Culture of Quality was developed by the American Joint Committee on Cancer (AJCC), Commission on Cancer (CoC), American College of Surgeons Clinical Research Program (ACS CRP), National Accreditation Program for Breast Centers (NAPBC), and National Cancer Database (NCDB). Attend and be able to:
- Identify current issues impacting cancer providers’ ability to provide cancer patients and those with diseases of the breast high-quality, patient-centered care.
- Explain the importance of staff involvement in the collection and review of patient demographics and data for community outreach, prevention and screening, quality improvement and program administration.
- Describe best practices and evaluate the appropriateness for implementation at individual programs/centers.
- Develop and utilize quality tools and benchmarks to monitor and continually evaluate their program’s performance.
Saturday, Sept. 9 Featured Session – Review and Impact of the NCDB PUF
Sandra Wong, MD, MS, FACS, will address how investigators associated with CoC-accredited cancer programs are able to apply for an NCDB Participant User File (PUF) and the impact that the data has on patient care at the local and national level. The session will also focus on two programs' with experience using NCDB data within their facility:
- Preoperative Prediction of Node Negative Disease After Neoadjuvant Chemotherapy in Patients Presenting with Node Negative or Node Positive Breast Cancer – Brittany Murphy, MD
- Race‐based Socioeconomic and Treatment Disparities in Adolescents and Young Adults (AYAs) with Stage II‐III Rectal Cancer – Melanie Goldfarb, MD, MSc., FACS, FACE
|
Promoted by
|
|
|
|
 |
News-Medical.Net
Investigators from Brigham and Women's Hospital and the Harvard Stem Cell Institute have a potential solution for how to kill tumor cells that have metastasized to the brain. The team has developed cancer-killing viruses that can deliver stem cells via the carotid artery, and applied them to metastatic tumors in the brain of clinically relevant mouse models. The investigators report the elimination of metastatic skin cancer cells from the brain of these preclinical models, resulting in prolonged survival. The study, published online this week in the journal PNAS, also describes a strategy of combining this therapy with immune checkpoint inhibitors.
READ MORE
 |
|
Doctors Without Borders/Médecins Sans Frontières (MSF) is actively recruiting general and trauma surgeons with experience in emergency obstetrics for international missions in developing countries. Learn more.
|
|
CoC
The Commission on Cancer (CoC) is looking to identify potential presenters for the 2018 CoC Oncology Lecture at the American College of Surgeons Clinical Congress 2018 on Oct. 21-25, 2018 in Boston. This is one of 11 named lectures that are a part of the Clinical Congress.
The annual Commission on Cancer Oncology Lecture was instituted to focus on current, major developments in oncology and emphasize the role that the surgeon has in caring for patients with cancer. The lecturer should be a recognized leader in the field of oncology who has been involved in clinical and/or laboratory research, and/or cancer management. For 2018, we are seeking experts in one or more of the following areas:
- Cancer immunotherapy
- Palliative care
- Surgical clinical trials in the United States
- Survivorship care
Please click here to suggest up to three names of speakers for 2018. The speakers do not have to be surgeons.
Thank you in advance for assistance. Your response is due by Friday, July 28.
READ MORE
|
|
Your unused cancer medications can save a life. SafeNetRx, the Iowa Cancer Consortium and the Iowa Department of Public Health have partnered to increase the donations of cancer fighting drugs to the Iowa Drug Donation Repository. Learn more about this program and how you can donate to patients in need.
Read more
|
|
|
|
|
Reach Your Prospects Every Week
Thousands of industry professionals subscribe to association news briefs, which allows your company to push messaging directly to their inboxes and take advantage of the association's brand affinity.
Connect with Highly Defined Buyers and Maximize Your Brand Exposure
|
|
|
|
|
Cure
With the FDA approval of two new PARP inhibitor drugs since last year's Ovarian Cancer National Conference, it's no surprise the topic was of great interest at this year's meeting in Chicago, and a standing-room-only crowd was on hand July 8 to hear the latest news on this practice-changing class of drugs.
"There is a dizzying amount of data with respect to how effective they are, how tolerable they are, and when it's best to use them," noted John Moroney, MD, the expert on hand to lead the discussion.
READ MORE
ACS-CoC
The American College of Surgeons (ACS) is seeking six Fellows to fill vacancies on the Commission on Cancer (CoC). The initial term of appointment is three years with eligibility for re-election to a second term. Members may hold office or serve as Vice-Chair of a committee or subcommittee during their second term. New members will be recommended by the Nominating Committee, selected in October by the Executive Committee, and then brought before the full CoC membership for approval at the CoC Annual Meeting. The ACS Board of Regents will confirm the final list of new members, and the CoC will announce the new members in late October.
READ MORE
Reuters
Torn from their homes and families, Jewish holocaust survivors endured starvation, enslavement and staggering physical and emotional abuse at the hands of the Nazis during World War II.
Now, a study released recently shows that survivors suffer an elevated risk of cancer, especially lung and colorectal malignancies.
Israeli researchers examined the medical records of more than 152,000 holocaust survivors over more than 45 years and compared those who qualified for compensation as a result of their persecution during the war with those whose compensation bids were rejected.
READ MORE
ACS
Registration is now open for the American College of Surgeons Clinical Congress 2017, Oct. 22–26 in San Diego. Clinical Congress is one of the largest meetings of surgeons in the world and offers outstanding educational opportunities for every stage of your career. The theme of this year's conference is Do What's Right for the Patient.
READ MORE
USA Today
Researchers find massive amounts of Vitamin D could be the answer to the summertime nemesis of every pale person: The blistering, crimson sunburn.
People who took huge doses of the vitamin an hour after a sunburn saw long-term benefits — significant reductions in redness, swelling and inflammation. That's according to researchers at the Case Western Reserve University School of Medicine. The school's study was the first-ever trial to exhibit the anti-inflammatory perks of Vitamin D.
READ MORE
|
Missed last week's issue? See which articles your colleagues read most.
|
Don't be left behind. Click here to see what else you missed.
|
|
|
The Brief
Connect with AJCC
Connect with CoC
Connect with NAPBC
Recent Issues | Subscribe | Unsubscribe | Advertise | Web Version
Colby Horton, Vice President of Publishing, 469-420-2601 | Download media kit
Ashley Harrington, Senior Content Editor, 469-420-2642 | Contribute news
Disclaimer: The Brief is a digest of news selected for the Commission on Cancer (CoC) and the National Accreditation Program for Breast Centers (NAPBC), both quality programs of the American College of Surgeons, from thousands of sources by the editors of MultiBriefs, an independent organization that also manages and sells advertising. The CoC and NAPBC do not endorse any of the advertised products and services. Opinions expressed in the articles are those of the author and not of the American College of Surgeons, the CoC and the NAPBC.
American College of Surgeons
633 N Saint Clair Street | Chicago, IL, 60611-3211 | 800-621-4111 | Contact Us
Learn how to add us to your safe sender list so our emails get to your inbox. |
|
| |
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
